Partner Josephine Young has been selected to serve on Law360’s life sciences editorial advisory board. Law360’s editorial boards offer insights from top practitioners and other highly informed sources on how Law360 can improve its coverage. Editorial board members keep section editors apprised of significant trends and cases and provide reporters with a pool of knowledgeable sources. Law360 editorial board appointments last for one year.  

Josie has nearly 15 years of experience litigating high-stakes biotechnology and pharmaceutical patent cases. Her many successes in high-value patent disputes include her contributions to Groombridge, Wu, Baughman & Stone LLP’s PTAB win for Novo Nordisk, the maker of Ozempic®, Wegovy®, and Rybelsus®. She is registered to practice at the U.S. Patent and Trademark office and, earlier in her career, was a Patent Examiner with the USPTO.